What’s the Medical Consensus on Red Light Therapy?

Interest in red light therapy has grown quickly across medicine, rehabilitation, athletics, skincare, and personal wellness. That growing awareness has also created confusion. Research studies often use different wavelengths, doses, treatment schedules, and types of light. At the same time, the claims surrounding red light therapy can range from appropriately cautious to wildly expansive.

A recent evidence-based consensus paper offers something the field has needed: a clearer picture of what medical experts currently agree on.

After reviewing the published research, an international expert panel reached consensus on 38 statements covering the safety, biological effects, treatment parameters, and clinical applications of photobiomodulation.¹ The findings provide a useful framework for understanding where the evidence is strongest, which questions remain unanswered, and why professionally guided treatment matters.

Illustration showing a group of medical experts sharing information

How the Medical Consensus Was Developed

This was not a new clinical trial involving a single condition or treatment protocol. The researchers first conducted a systematic review of the medical literature. They then assembled 21 experts with backgrounds in areas including:

  • Dermatology
  • Neuroscience
  • Physical rehabilitation
  • Dentistry
  • Internal medicine
  • Physiology
  • Physical therapy

The panel completed two rounds of structured surveys, participated in two consensus meetings, and reviewed the recommendations until agreement was reached.

For a statement to qualify as consensus, at least 80% of the experts had to agree or strongly agree with it. The panel eventually reached consensus on 38 statements covering the basic science, safety, treatment parameters, and clinical uses of photobiomodulation.¹

This process does not make every statement permanent or beyond debate, but it does provide a structured snapshot of the medical evidence as it currently stands.

Is Photobiomodulation Considered Safe?

The panel concluded that photobiomodulation is generally a safe treatment modality for adults when it is used appropriately. Reported side effects were usually mild, temporary, and self-resolving. These could include brief discomfort, redness, warmth, or irritation.¹

The experts also found that severe adverse events had not been reported in the research they reviewed. The takeaway is reassuring but measured: red light therapy has a favourable safety profile for adults, but it should still be used with appropriate treatment parameters and precautions.

Does Red Light Cause DNA Damage?

Ultraviolet light is known to cause forms of DNA damage associated with premature aging and skin cancer. Red light occupies a different part of the light spectrum and interacts with tissue differently.

The expert panel agreed that red and near-infrared photobiomodulation do not produce the forms of DNA damage typically associated with ultraviolet exposure. The research cited by the panel found that red light did not create these markers of DNA damage in human skin cells, even at relatively high doses.¹

How Does Photobiomodulation Affect the Body?

Photobiomodulation uses specific wavelengths of visible red and near-infrared light to influence biological activity. The expert panel identified cytochrome c oxidase, an enzyme found within the mitochondria, as an important light-sensitive component in this process. Mitochondria help cells convert nutrients and oxygen into usable energy.

By interacting with these cellular processes, photobiomodulation may influence energy production, circulation, inflammation, and tissue repair. The panel also emphasized that the response can vary with dose. Depending on the treatment parameters, light may produce either a stimulatory or inhibitory effect.¹ This is one reason the phrase “more is better” does not apply neatly to red light therapy.

Which Clinical Applications Have the Strongest Support?

The panel reviewed research across a wide range of medical and aesthetic applications. It did not conclude that photobiomodulation is effective for every condition.

Consensus was reached in several areas, including the following.

Peripheral neuropathy

The panel concluded that photobiomodulation can be used as an adjunct therapy for peripheral neuropathy.

Wound healing and ulcers

The experts agreed that photobiomodulation can accelerate wound healing and may be considered alongside conventional treatment for wounds from several causes.

The panel also supported its adjunctive use for pain associated with diabetic foot ulcers and for certain pressure ulcers.¹

Pattern hair loss

The evidence supported photobiomodulation as an option for promoting hair regrowth in androgenic alopecia, commonly known as male- or female-pattern hair loss.

The panel did not reach the same conclusion for every type of hair loss.

Acute radiation dermatitis

The experts agreed that photobiomodulation can help reduce the incidence and severity of acute radiation dermatitis, an inflammatory skin reaction that may develop during radiation therapy.¹

The paper also found support for improving scar outcomes and supporting skin rejuvenation.

Why Treatment Parameters Matter

One of the most important findings was not tied to any single condition. The panel emphasized that the biological effects of photobiomodulation depend on how the light is delivered. Important treatment parameters include:

  • Wavelength
  • Energy dose
  • Distance between the light source and the tissue
  • Length of each treatment
  • Size of the treatment area
  • Treatment frequency
  • Total treatment duration

Different combinations may produce different biological responses. A protocol that works well for one tissue or condition cannot automatically be applied to another.

This is also why home products and professionally delivered photobiomodulation treatments should not all be treated as interchangeable.

At RegenClinic, treatments are provided by trained professionals who consider the treatment area, purpose, dose, timing, and broader care plan. The goal is not simply to expose the body to red light. It is to deliver an appropriate amount of light in a thoughtful and consistent way.

🌿

Do you have questions about photobiomodulation or whether it may complement your current care? Connect with the RegenClinic team. We’re always happy to help you understand the research and explore your options.

Call or text us at 250-208-4218
Email: hello@regenclinic.ca

Reference:
1. Maghfour J, Mineroff J, Ozog DM, et al. Evidence-based consensus on the clinical application of photobiomodulation. Journal of the American Academy of Dermatology. 2025;93(2). doi:10.1016/j.jaad.2025.04.031